VGHCX
Vanguard Health Care Fund Investor Shares
1W: +0.6%
1M: -6.5%
3M: -4.9%
YTD: -4.6%
1Y: +6.8%
3Y: +16.7%
5Y: +29.0%
$194.32
-1.38 (-0.71%)
ETF-Level Metrics
AUM$40.5B
Holdings80
Top 10 Wt42.0%
Beta0.70
% Profitable51%
Coverage96%
Portfolio Valuation
P/E749.3
P/B126.7
P/S106.2
EV/EBITDA15.1
P/FCF996.4
PEG30.67
Profitability & Returns
Gross Margin67.1%
Net Margin14.1%
ROE17.4%
ROA9.4%
ROIC20.1%
Div Yield1.27%
Leverage & Liquidity
Debt/Equity0.28
Debt/Assets0.15
Net Debt/EBITDA-0.1x
Interest Cov19.1x
Current Ratio1.97
Quick Ratio1.54
Growth (YoY)
Revenue+24.8%
Net Income+42.7%
EPS+54.5%
FCF+66.7%
EBITDA+47.8%
Rev CAGR 3Y+19.6%
Quality Scores
Piotroski F6.5
Altman Z9.51
IS Quality73.1
IS Overall62.8
IS Value43.4
Median P/E16.3
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 79 | 94.9% | -50.0 |
| Other | 19 | 3.3% | — |
| Consumer Defensive | 1 | 1.5% | 51.6 |
Smart Money Overlap
8 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | 4.15% | 4 | Bullish | 11 | 2 | +0.5% |
| JNJ | Johnson & Johnson | 2.64% | 4 | Bullish | 12 | 2 | -1.2% |
| BSX | Boston Scientific Corporation | 2.38% | 4 | Bullish | 8 | 6 | -5.3% |
| CAH | Cardinal Health, Inc. | 1.44% | 4 | Bullish | 1 | 1 | -2.6% |
| BIIB | Biogen Inc. | 1.38% | 4 | Bullish | 1 | 1 | -2.3% |
| LH | Labcorp Holdings Inc. | 0.57% | 4 | Bullish | 11 | 7 | -4.7% |
| OPCH | Option Care Health, Inc. | 0.39% | 4 | Bullish | 1 | 2 | +5.0% |
| PFE | Pfizer Inc. | 0.34% | 4 | Bullish | 11 | 2 | +3.7% |
Showing 50 of 99 holdings
· Page 1 of 2
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 9.72% | $3.6B | 4,221,645 | 39.0 | $847.1B | Healthcare |
| 2 | AstraZeneca PLC | ZEG.DE | 5.77% | $2.8B | 13,113,119 | 28.4 | $249.2B | Healthcare |
| 3 | UnitedHealth Group Inc | UNH.BA | 4.35% | $1.6B | 4,772,250 | 20.2 | $351.1T | Healthcare |
| 4 | Merck & Co Inc | MRK | 4.15% | $1.6B | 18,106,656 | 16.2 | $294.1B | Healthcare |
| 5 | Edwards Lifesciences Corp | EW | 3.39% | $1.3B | 15,419,708 | 44.5 | $47.7B | Healthcare |
| 6 | Vertex Pharmaceuticals Inc | VRTX | 3.37% | $1.3B | 2,971,156 | 29.1 | $115.2B | Healthcare |
| 7 | AbbVie Inc | ABBV | 2.91% | $1.1B | 5,007,334 | 88.9 | $373.3B | Healthcare |
| 8 | Intuitive Surgical Inc | ISRG | 2.87% | $1.1B | 2,011,562 | 58.2 | $166.4B | Healthcare |
| 9 | GSK PLC | GLAXF | 2.83% | $1.4B | 45,301,487 | 14.4 | $109.0B | Healthcare |
| 10 | Johnson & Johnson | JNJ | 2.64% | $991.0M | 5,247,008 | 21.7 | $576.5B | Healthcare |
| 11 | Argenx SE | ARGNF | 2.55% | $1.1B | 1,165,992 | 38.0 | $50.4B | Healthcare |
| 12 | Cencora Inc | ABC | 2.44% | $913.2M | 2,703,255 | 38.0 | $36.1B | Healthcare |
| 13 | Boston Scientific Corp | BSX | 2.38% | $893.2M | 8,868,300 | 36.0 | $104.1B | Healthcare |
| 14 | Danaher Corp | DHR | 2.28% | $854.2M | 3,966,085 | 36.8 | $133.0B | Healthcare |
| 15 | Medtronic PLC | MDT | 2.11% | $791.9M | 8,730,612 | 24.4 | $112.6B | Healthcare |
| 16 | UCB SA | UCB.BR | 2.02% | $874.6M | 2,950,859 | 30.6 | $47.8B | Healthcare |
| 17 | Thermo Fisher Scientific Inc | TMO | 1.61% | $602.2M | 1,061,273 | 27.4 | $181.6B | Healthcare |
| 18 | Alnylam Pharmaceuticals Inc | ALNY | 1.59% | $597.0M | 1,309,033 | 138.3 | $43.5B | Healthcare |
| 19 | Roche Holding AG | ROG.SW | 1.55% | $723.3M | 1,797,049 | 19.3 | $256.6B | Healthcare |
| 20 | Elevance Health Inc | ANTM | 1.53% | $574.0M | 1,809,696 | 11.5 | $114.6B | Healthcare |
| 21 | Agilent Technologies Inc | A | 1.52% | $569.8M | 3,892,828 | 24.9 | $32.1B | Healthcare |
| 22 | Galderma Group AG | GALD.SW | 1.49% | $694.9M | 3,011,146 | 51.6 | $35.5B | Consumer Defensive |
| 23 | Cardinal Health Inc | CAH | 1.44% | $539.3M | 2,827,157 | 29.4 | $48.9B | Healthcare |
| 24 | Bristol-Myers Squibb Co | BMY | 1.42% | $530.6M | 11,516,757 | 17.2 | $121.0B | Healthcare |
| 25 | Biogen Inc | BIIB | 1.38% | $518.8M | 3,362,885 | 21.7 | $28.0B | Healthcare |
| 26 | Daiichi Sankyo Co Ltd | 4568.T | 1.28% | $3.1M | 20,084,066 | 17.8 | $5.3T | Healthcare |
| 27 | Novartis AG | NOVN.SW | 1.25% | $583.7M | 3,795,144 | 20.4 | $228.1B | Healthcare |
| 28 | United Therapeutics Corp | UTHR | 1.16% | $434.2M | 974,740 | 17.7 | $23.3B | Healthcare |
| 29 | Otsuka Holdings Co Ltd | OTSKF | 1.15% | $2.8M | 7,893,800 | 16.5 | $36.2B | Healthcare |
| 30 | Abbott Laboratories | ABT.SW | 1.08% | $405.3M | 3,278,810 | 28.0 | $146.8B | Healthcare |
| 31 | Genmab A/S | GNMSF | 1.02% | $59.3M | 1,345,944 | 26.0 | $16.5B | Healthcare |
| 32 | Chugai Pharmaceutical Co Ltd | 4519.T | 1.01% | $2.5M | 8,280,342 | 32.4 | $13.9T | Healthcare |
| 33 | HCA Healthcare Inc | HCA | 0.94% | $351.2M | 764,019 | 16.3 | $107.4B | Healthcare |
| 34 | Ionis Pharmaceuticals Inc | 0JDI.L | 0.70% | $262.3M | 3,530,197 | -31.6 | $11.9B | Healthcare |
| 35 | Eisai Co Ltd | 4523.T | 0.67% | $1.6M | 8,514,317 | 32.7 | $1.4T | Healthcare |
| 36 | Novo Nordisk A/S | NOVO-B.CO | 0.65% | $37.4M | 4,927,319 | 10.0 | $1.1T | Healthcare |
| 37 | Astellas Pharma Inc | 4503.T | 0.64% | $1.6M | 23,022,078 | 14.5 | $4.5T | Healthcare |
| 38 | Cytokinetics Inc | CYTK | 0.63% | $236.8M | 3,723,473 | -9.9 | $7.8B | Healthcare |
| 39 | Stryker Corp | SYK | 0.61% | $227.4M | 638,235 | 39.2 | $127.3B | Healthcare |
| 40 | Ascendis Pharma A/S | ASND | 0.59% | $222.5M | 1,103,469 | -51.6 | $13.5B | Healthcare |
| 41 | Avantor Inc | AVTR | 0.59% | $222.3M | 18,803,027 | -9.8 | $5.2B | Healthcare |
| 42 | QIAGEN NV Private | — | 0.58% | $216.5M | 4,620,121 | — | — | — |
| 43 | Labcorp Holdings Inc | LH | 0.57% | $213.7M | 841,556 | 25.3 | $22.2B | Healthcare |
| 44 | ICON PLC | ICLR | 0.55% | $207.2M | 1,206,172 | 13.3 | $7.9B | Healthcare |
| 45 | Shionogi & Co Ltd | SGIOF | 0.53% | $1.3M | 11,891,049 | 15.4 | $17.0B | Healthcare |
| 46 | Amicus Therapeutics Inc | FOLD | 0.50% | $188.7M | 20,893,978 | -164.5 | $4.5B | Healthcare |
| 47 | REVOLUTION Medicines Inc | RVMDW | 0.48% | $181.2M | 3,079,283 | -15.7 | $327M | Healthcare |
| 48 | Guardant Health Inc | GH | 0.47% | $176.8M | 1,900,793 | -27.2 | $11.6B | Healthcare |
| 49 | Apellis Pharmaceuticals Inc | APLS | 0.47% | $175.5M | 8,174,279 | 99.3 | $2.3B | Healthcare |
| 50 | Charles River Laboratories International Inc | CRL | 0.46% | $174.2M | 967,609 | -56.3 | $8.1B | Healthcare |